About the Speaker

Giustino Di Pretoro is a Scientific Director at Janssen Pharmaceutica, a Johnson & Johnson Company. He is a subject matter expert and drug product development lead for continuous manufacturing, and coordinator for a series of academic collaborations within the field. Before joining Johnson & Johnson, Giustino was Team Leader and Principal Scientist at Novo Nordisk AS in Denmark and was previously R&D and Business Development Manager for a Swiss contract manufacturing organisation, focussing on novel technologies. Giustino holds a Ph.D. in Pharmaceutical Technology and an MSc.in Industrial Pharmacy from the University of Milan. During his Ph.D. he worked as a Research Scientist in the Chemical Engineering and Biotechnology Department, Cambridge University, England and later as a visiting postdoc in Pharmaceutical Technology at the University of Düsseldorf, Germany.

 

About the Webinar

For more than 50 years, pharmaceuticals have been produced using a method known as “batch manufacturing,” a multi-step, lengthy process that usually involves the use of large-scale equipment. However, recent advances in manufacturing technology have prompted the pharmaceutical industry to consider moving away from batch manufacturing to a faster, more efficient process known as “continuous manufacturing”. The Regulatory Agencies are taking proactive steps to facilitate the pharma industry’s implementation of emerging technologies, including continuous manufacturing, to improve product quality and to address many of the underlying causes of drug shortages and recalls. Our speaker will provide his expert practical experience of continuous manufacturing.

 

Learning Outcomes

By the end of this webinar, you will be able to: −

  • Define the differences between continuous and batch manufacture.
  • Understand why the transition to continuous manufacture in many pharma companies is still in its early stages.
  • Reflect on a leading industrial expert’s opinion on the advantages of continuous manufacture.
  • Understand the official definitions of batch and control strategies in continuous manufacturing.
  • Know where to find information and advice on the transition to continuous manufacture.

 

See event flyer for registration details EIPG Continuous Manufacturing of Pharmaceuticals: Higher Quality, Greater Flexibility_30 March 2022

Get in touch


PIER,
C/o School of Pharmacy,
Cavanagh Building,
University College Cork.

Get in touch

Privacy policy

We're Social





Mailing List Signup

Email address: